PL2442831T3 - Materiały i sposoby dotyczące glikozylacji polipeptydu terapeutycznego - Google Patents

Materiały i sposoby dotyczące glikozylacji polipeptydu terapeutycznego

Info

Publication number
PL2442831T3
PL2442831T3 PL10727485T PL10727485T PL2442831T3 PL 2442831 T3 PL2442831 T3 PL 2442831T3 PL 10727485 T PL10727485 T PL 10727485T PL 10727485 T PL10727485 T PL 10727485T PL 2442831 T3 PL2442831 T3 PL 2442831T3
Authority
PL
Poland
Prior art keywords
glycosylation
materials
therapeutic polypeptide
methods relating
relating
Prior art date
Application number
PL10727485T
Other languages
English (en)
Inventor
Andrew Graham Watts
Amanda Barbara Mackenzie
Terrence Kantner
Original Assignee
Glythera Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glythera Ltd filed Critical Glythera Ltd
Publication of PL2442831T3 publication Critical patent/PL2442831T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549Sugars, nucleosides, nucleotides or nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PL10727485T 2009-06-16 2010-06-16 Materiały i sposoby dotyczące glikozylacji polipeptydu terapeutycznego PL2442831T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18743409P 2009-06-16 2009-06-16
EP10727485.4A EP2442831B9 (en) 2009-06-16 2010-06-16 Materials and methods relating to glycosylation of a therapeutic polypeptide
PCT/GB2010/001188 WO2010146362A2 (en) 2009-06-16 2010-06-16 Materials and methods relating to glycosylation

Publications (1)

Publication Number Publication Date
PL2442831T3 true PL2442831T3 (pl) 2016-06-30

Family

ID=43086298

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10727485T PL2442831T3 (pl) 2009-06-16 2010-06-16 Materiały i sposoby dotyczące glikozylacji polipeptydu terapeutycznego

Country Status (8)

Country Link
US (1) US9452223B2 (pl)
EP (1) EP2442831B9 (pl)
JP (2) JP6091892B2 (pl)
CN (1) CN102481377B (pl)
CA (1) CA2768155C (pl)
ES (1) ES2560557T3 (pl)
PL (1) PL2442831T3 (pl)
WO (1) WO2010146362A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2560557T3 (es) * 2009-06-16 2016-02-19 Glythera Limited Materiales y métodos con relación a la glicosilación de polipéptidos terapéuticos
TW201442721A (zh) * 2013-01-23 2014-11-16 Daiichi Sankyo Co Ltd 糖鏈修飾心房利尿鈉肽
WO2015148915A1 (en) * 2014-03-27 2015-10-01 Academia Sinica Reactive labelling compounds and uses thereof
RU2656140C2 (ru) * 2016-11-14 2018-05-31 Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России Способ получения гибридного белка, состоящего из рекомбинантного белка аналога интерферона гамма, конъюгированного с олигосахаридом

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE193551T1 (de) * 1991-03-18 2000-06-15 Scripps Research Inst Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen
US5770407A (en) 1996-12-10 1998-06-23 The Scripps Research Institute Process for preparing nucleotide inhibitors of glycosyltransferases
EP2042196B1 (en) * 2001-10-10 2016-07-13 ratiopharm GmbH Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
US7226903B2 (en) * 2001-10-10 2007-06-05 Neose Technologies, Inc. Interferon beta: remodeling and glycoconjugation of interferon beta
MXPA05003978A (es) * 2002-10-16 2005-06-22 Scripps Research Inst Sintesis de glicoproteinas.
KR20100016160A (ko) * 2007-04-03 2010-02-12 바이오제너릭스 에이지 글리코페길화 g―csf를 이용하는 치료 방법
CA2704234A1 (en) * 2007-11-09 2009-05-14 Baxter International Inc. Modified recombinant factor viii and von willebrand factor and methods of use
ES2560557T3 (es) * 2009-06-16 2016-02-19 Glythera Limited Materiales y métodos con relación a la glicosilación de polipéptidos terapéuticos

Also Published As

Publication number Publication date
US20120190631A1 (en) 2012-07-26
HK1169336A1 (zh) 2013-02-22
JP2012530119A (ja) 2012-11-29
CA2768155C (en) 2016-08-23
WO2010146362A2 (en) 2010-12-23
CA2768155A1 (en) 2010-12-23
CN102481377B (zh) 2014-10-29
EP2442831B9 (en) 2016-05-11
EP2442831B1 (en) 2015-11-04
CN102481377A (zh) 2012-05-30
JP2015187153A (ja) 2015-10-29
ES2560557T3 (es) 2016-02-19
US9452223B2 (en) 2016-09-27
WO2010146362A3 (en) 2011-06-30
JP6091892B2 (ja) 2017-03-08
EP2442831A2 (en) 2012-04-25

Similar Documents

Publication Publication Date Title
ZA201107702B (en) Composition and methods related to protein a(spa)variants
ZA201209561B (en) Compositions and methods related to protein a (spa) variants
HRP20181602T1 (hr) Postupak pročišćavanja prokariotskih varijanti i fenilalanin-amonijak-lijaze
IL262567B (en) Concentrated therapeutic phospholipid compositions
EP2547771A4 (en) PREPARATION OF PROTEINS AND POLYPEPTIDES
RU2557654C3 (ru) Терапевтические агенты для снижения уровней паратиреоидного гормона
EP2539707A4 (en) ARTIFICIAL MYCOLIC ACID MEMBRANES
PL3299380T3 (pl) Sposoby oczyszczania polipeptydów
BR112013013308A2 (pt) inalador e unidade articulada
IL232247A0 (en) Polypeptide constructs and uses thereof
DK2437762T3 (da) Kunstige tårer og terapeutiske anvendelser
IL252490A0 (en) Ceramic-ceramic bonding and related methods
IL232073A0 (en) Recombinant human naglu protein and its uses
PL2575778T3 (pl) KOMPOZYCJE FARMACEUTYCZNE KOKRYSZTAŁÓW TRAMADOLU i KOKSYBÓW
IL226359B (en) Use of t-cells for the preparation of a medicament for treatment of neurodegenerative diseases
IL232645B (en) Recombinant proteins and their therapeutic uses
EP2519636A4 (en) PREPARATION OF A HEMAGGLUTININE NEURAMINIDASE PROTEIN IN MICROALGEN
LTPA2018512I1 (lt) Rekombinantinės lizosominės alfa manozidazės gamybos ir gryninimo būdas
IT1402374B1 (it) Miglioramenti in e relativi a composizioni farmaceutiche
ME02992B (me) Intermedijeri agomelaтina i postupci njihove priprave
PL2442831T3 (pl) Materiały i sposoby dotyczące glikozylacji polipeptydu terapeutycznego
BR112013007285A2 (pt) composto de polihidroxila monocatiônico e método para prover hidratação a uma composição para cuidado pessoal
BR112012018393A2 (pt) composição de shampoo e método de fabricação de uma composição de shampoo
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
FI20095792L (fi) Ihmissolujen käyttö